Psychiatry and Neurology, Neurology · Atlantis, FL
NPI
1932358009
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
140 JFK Dr
Atlantis, FL, 33462
Phone (561) 968-6767
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
14,005 services
Medicare patients, 2024
515
Average age 77
Drug cost, 2024
$6.9M
2,365 prescriptions
Company payments, 2025
$3,668
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose R Labault-Santiago was code J0585 (injection, onabotulinumtoxina, 1 unit), 13,000 times for 33 patients. In total Jose R Labault-Santiago billed 14,005 services in 43 codes, and Medicare paid $161K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 13,000 | 33 | $4.96 | $65K |
| 99214 Office E&M - Established | Office | 191 | 169 | $87.14 | $17K |
| 99213 Office E&M - Established | Office | 166 | 136 | $65.96 | $11K |
| 95886 Electrical Nerve Conductivity | Office | 104 | 97 | $73.76 | $7,671 |
| 99204 Office E&M - New | Office | 96 | 96 | $115.90 | $11K |
| 95913 Electrical Nerve Conductivity | Office | 63 | 63 | $216.61 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 50 | 50 | $11.97 | $598 |
| 95910 Electrical Nerve Conductivity | Office | 48 | 48 | $129.42 | $6,212 |
| 95874 Musculoskeletal | Office | 38 | 14 | $56.63 | $2,152 |
| 64644 Musculoskeletal | Office | 37 | 13 | $127.59 | $4,721 |
| 64615 Musculoskeletal | Office | 32 | 17 | $117.32 | $3,754 |
| 99223 Hospital E&M - Initial | Facility | 31 | 31 | $132.85 | $4,118 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 15 | $62.46 | $1,062 |
| 95819 Neurologic | Office | 15 | 15 | $353.39 | $5,301 |
| 95819 Neurologic | Facility | 13 | 13 | $43.82 | $570 |
By year: 2022 $181K for 18,228 services; 2023 $180K for 17,177 services; 2024 $161K for 14,005 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose R Labault-Santiago prescribed most often to Medicare patients was Gabapentin, with 666 prescriptions and refills. In total Jose R Labault-Santiago wrote 2,365 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 666 | 1,018 | 244 | $9,281 |
| Pregabalin Generic | 218 | 274 | 63 | $3,366 |
| Prednisone Generic | 185 | 246 | 36 | $1,240 |
| Pyridostigmine Bromide Generic | 140 | 265 | 40 | $11K |
| Botox Onabotulinumtoxina | 125 | 355 | 47 | $142K |
| Levetiracetam Generic | 79 | 174 | 24 | $1,284 |
| Topiramate Generic | 52 | 104 | 11 | $381 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 52 | 68 | Under 11 | $945K |
| Memantine Hcl Generic | 50 | 102 | 11 | $1,134 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 48 | 108 | 18 | $667 |
| Mycophenolate Mofetil Generic | 45 | 79 | 12 | $2,309 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 39 | 41 | Under 11 | $521K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 38 | 38 | Under 11 | $822K |
| Nortriptyline Hcl Generic | 37 | 87 | 12 | $706 |
| Donepezil Hcl Generic | 37 | 89 | 20 | $489 |
Brand drugs: 493 claims; generic drugs: 1,872 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose R Labault-Santiago $3,668 ($3,668 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $887.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 43 | $887 |
| UCB, Inc. UCB.BR | 10 | $402 |
| Pfizer Inc. PFE | 17 | $399 |
| Eisai Inc. 4523.T | 14 | $358 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $316 |
| Lilly USA, LLC LLY | 10 | $187 |
| Neurocrine BioSciences, Inc. NBIX | 9 | $186 |
| Biogen, Inc. BIIB | 6 | $123 |
| Neurelis, Inc. | 7 | $122 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $87.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.